Skip to main content
OpenTrials
Completed

NCT Number: NCT04779138

Increasing Vaccine Uptake in Underresourced Public Housing Areas

This proposal seeks to enhance uptake and completion of COVID-19 vaccination among African American and Latinx public housing residents in South Los Angeles. Given the multiple disparities experienced by public housing residents, the investigators will utilize a theoretically-based, multidisciplinary and culturally tailored intervention to provide education at multiple levels and implement innovate strategies to engage this population in the uptake of COVID-19 vaccination.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Coronavirus Behavior Coronaviridae Infections Coronavirus Infections Health Behavior Infections Nidovirales Infections RNA Virus Infections Treatment Adherence and Compliance Treatment Refusal Vaccination Refusal Vaccine Refusal Virus Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Charles R. Drew University of Medicine & Science

Los Angeles, California, 90059, United States

About this study

One particular group, African American and Latinx public housing residents, are facing adverse effects related to worsening social determinants and health disparities. Utilizing a community-driven approach, the overall objective of this proposed study is to increase COVID-19 vaccine uptake and completion the impact of COVID-19 among African American and Latinx public housing residents. Guided by the Community Based Participatory Model, the Information, Motivation, and Behavioral Skills (IMB) and the Transtheoretical Model will be utilized to carry out this intervention. Through this innovative program, we will establish Academic-Community Team for Improving Vaccine Acceptability and Targeted Engagement (ACTIVATE) program, which will develop leadership triads of public housing resident leaders, nurse practitioner students, and public health students to carry out this multilevel intervention.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Aim 2:

Inclusion criteria

  • identify as Latinx or African American
  • age 18 or older
  • reside in one of the six collaborating public housing area
  • Speak either English or Spanish

Exclusion criteria

  • Not a resident at one of the collaborating public housing areas
  • Does not self-identify as African American or Latinx
  • Age 17 and younger
  • Unable to speak either English or Spanish

Aim 3:

Inclusion criteria

  • identify as Latinx or African American
  • age 18 or older
  • reside in one of the six collaborating public housing area
  • Speak either English or Spanish
  • Report vaccine hesitancy

Exclusion criteria

  • Not a resident at one of the collaborating public housing areas
  • Does not self-identify as African American or Latinx
  • Age 17 and younger
  • Unable to speak either English or Spanish
  • Received all recommended vaccines for COVID-19
  • No reporting of vaccine hesitancy

Treatment and study plan

Increasing Willingness and Uptake of COVID-19 Vaccination

Behavioral

Provide/enhance knowledge, modify attitudes, motivate and provide skills and resources to reduce COVID-19 vaccine hesitancy and increase willingness and uptake in COVID-19 vaccination.

Primary outcomes

  1. Prevalence of vaccination uptake for COVID-19, influenza, and pneumonia using Vaccination History Self Report

    Time frame: Intervention: 4 months; Follow-up Point: 3 months post-intervention

    • By comparison of pre-, post- intervention, and 9- and 18-months follow-up data, we anticipate the following compared to baseline: a 40% change in completion of COVID-19 vaccination series

Secondary outcomes

  1. Percentage of Participants Achieving Decreased Vaccine Hesitancy Levels of COVID-19 vaccine Using the NIH Toolbox Surveys on COVID-19

    Time frame: Intervention: 4 months; Follow-up Point: 3 months post-intervention

    • By comparison of pre-, post- intervention, and 3-months follow-up data, we anticipate the following compared to baseline: a 40% change in hesitancy toward COVID-19 vaccination.

  2. Percentage of Participants Achieving Increased Level of Behavior Change toward COVID-19 Vaccination Using the NIH Toolbox Surveys on COVID-19

    Time frame: Intervention: 4 months; Follow-up Point: 3 months post-intervention

    • By comparison of pre-, post- intervention, and 3-months follow-up data, we anticipate the following compared to baseline: a 40% change in their behavior stage of change toward COVID-19 vaccination

Sponsors and collaborators

Lead sponsor

Charles Drew University of Medicine and Science

Other

Registry information

Official study title

Community Partnered Intervention to Increase COVID-19 Vaccine Uptake in Low Income Underresourced African Americans and Latinx Public Housing Residents

Important dates

Study start
2021
Primary completion
2023
Study completion
2024
First posted
Mar 3, 2021
Registry last updated
Apr 24, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.